48,830
edits
(fix sp. of koilocyte) |
|||
Line 70: | Line 70: | ||
Notes: | Notes: | ||
*Hyperchromasia is a very useful feature for identifying CIN (particularly at low power, i.e. 25x). | *Hyperchromasia is a very useful feature for identifying CIN (particularly at low power, i.e. 25x). | ||
* | *Koilocytes are the key feature of CIN I. | ||
* | *Koilocytes are ''not'' considered to be part of a CIN II lesion or CIN III lesion. | ||
*Large irregular nuclei are not required for CIN II... but you should think about it. | *Large irregular nuclei are not required for CIN II... but you should think about it. | ||
*Some mild changes at the squamo-columnar junction are expected. | *Some mild changes at the squamo-columnar junction are expected. | ||
Line 81: | Line 81: | ||
**Nucleoli are common in reactive changes.<ref>STC. January 2009.</ref> | **Nucleoli are common in reactive changes.<ref>STC. January 2009.</ref> | ||
==== | ====Koilocytes versus benign squamous==== | ||
Koilocytes: | |||
*Perinuclear clearing. | *Perinuclear clearing. | ||
*Nuclear changes. | *Nuclear changes. |
edits